Introduction
============

Opsoclonus-myoclonus syndrome (OMS) also known as the dancing eye syndrome is a very rare neurological disorder, affecting 1 in 10,000,000 people per year. In children, OMS was associated with neuroblastoma; in adults it may be associated with breast carcinoma or small-cell lung carcinoma, uterus or ovarian cancers, rare gall bladder, pancreas and renal cell carcinoma. It can also be consequent to toxic medication (amitriptyline, haloperidol, diazepam), metabolic disorders \[[@B1]\], hydroelectrolytic disorders, brain anoxia or autoimmune cause -- Hashimoto\'s encephalopathy \[[@B2]\], autoantibodies against neurons and cerebellar Purkinje cells \[[@B3]\], celiac disease, and one of the paraneoplastic syndromes. Although it is not considered an infectious disease, it can be associated with some viral infections, which may trigger the debut of OMS \[[@B4]\], such as the Epstein--Barr virus, coxsackie B2, B3 virus, Saint Louis encephalitis virus, human immunodeficiency virus \[[@B1]\], hepatitis C infection \[[@B5]\], rubella, mumps \[[@B6]\], varicella-zoster virus \[[@B7]\], and West Nile virus \[[@B8]\]. OMS was reported as a poststreptococcal infection associated with antibodies against a 56 kDa protein \[[@B9]\], in adolescents following an infection with *Mycoplasma pneumoniae*\[[@B10]\], *Rickettsia* and as a manifestation of acute *Borrelia burgdorferi* infection \[[@B11]\] and sometimes with vaccination. The conventional therapies with corticosteroids, intravenous immunoglobulin, plasmapheresis, adrenocorticotropin hormone, antiepileptic drugs are associated with long-term neurological morbidity; the combination of cyclophosphamide and dexamethasone pulse therapy \[[@B12]\] or rituximab administered in the refractory cases are promising \[[@B13],[@B14]\]. The best treatment in adults is not very clear. Steroids, baclofen, clonazepam, intravenous immunoglobulin, and immune-adsorption therapy are used currently \[[@B15]\].

We report a case of opsoclonus-myoclonus syndrome associated with West Nile encephalitis.

Case presentation
=================

Our patient was a 57-year-old Caucasian woman who had an acute onset of dizziness 2 days prior to presentation to hospital. She began to have fever, 38.8°C, vomiting, diarrhea, and sleepiness. Her past medical history was dominated by larynx neoplasm (surgically eradicated 4 years before) and high blood pressure. She was not on any medications. On admission she presented a respiratory rate of 26 breaths/minute, arterial oxygen saturation 93%, heart rate 72 beats/minute, blood pressure 120/80mmHg, opsoclonus with rapid, involuntary, multivectorial, conjugated fast eye movements persisting during sleep, no modification of her visual field, generalized myoclonus (brief, involuntary twitching of muscles), and she was unable to perform the finger to nose test; sleep disturbance, altered speech, mild neck stiffness, positive Kernig\'s sign, abnormal plantar responses and diminished osteotendinous reflexes. Work up included blood test and spinal fluid analysis, which are summarized in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} (only pathological results). Paraneoplastic antibodies anti-Hu, −Ri, −Yo were negative.

###### 

Cerebrospinal fluid studies

  **C**e**rebrospinal fluid**        **Results**
  ---------------------------------- ----------------------------------------------
  Nucleated cells                    49/mm^3^ -- 75% lymphocytes, 25% granulocyte
  Glucose                            115mg/dL
  Protein                            0.429g/L
  Gram smear                         No organism
  Culture                            No growth
  West Nile virus immunoglobulin M   Positive

###### 

Serum studies

  **Serum**                                           **Results**
  --------------------------------------------------- -----------------------------------------
  Glucose                                             236mg/dL
  Leukocytes                                          12,000/mm^3^
                                                      Granulocytes 79.7%, Ly 14.8%, Mxd 5.5%,
  Hemoglobin                                          15g/dL
  Hematocrit                                          42.4%
  West Nile virus immunoglobulin M 2nd serum sample   Positive, increase in evolution
  Lyme disease immunoglobulin M                       Negative

A cranial native computed tomography scan examination was performed and showed infra and supratentorial focused ischemia lesions.

The conclusions drawn from brain magnetic resonance imaging were: cortical and cerebellum atrophy; lacunary infarcts and bilateral infra-tentorial and over-tentorial demyelinating lesions; and ethmoid sinusitis.

She was given intravenous dexamethasone, symptomatic treatment with clonazepam, cerebral depletion treatment (such as administration of intravenous solutions like mannitol), supportive therapy with intravenous fluid, and antibiotics to prevent other types of bacterial infection. She had persistent OMS. After 2 weeks she presented an acute retention of urine and 4 weeks after admission she died. A postmortem examination did not reveal any malignancy, systemic diseases or toxic etiology.

Discussion
==========

The West Nile virus is a mosquito-borne zoonotic arbovirus of the *Flaviviridae* family that is found in temperate and tropical regions. It can cause a serious neurological illness in less than 1% of infected people: encephalitis, meningoencephalitis, acute flaccid paralysis -- poliomyelitis-like, Guillain--Barré syndrome and optic neuritis. In Romania, in 1996, the West Nile was responsible for a high number of neuroinvasive diseases. In recent years there has been a sporadic spread in this area, and a few cases of meningitis or encephalitis have been recorded annually. This is the first West Nile encephalitis with OMC diagnosed in our country. OMC may occur transiently in hyperglycemic coma but our patient presented hyperglycemia only on the first day after admission and the West Nile infection was shown both in her serum and cerebrospinal fluid (CSF) examination. Opsoclonus can be associated with severe evolution to an immunocompromised host. Her CSF examination was associated with a low CSF pleocytosis of 49 leukocytes/mm^3^ with 25% neutrophilic pleocytosis, more characteristic of West Nile neuroinvasive disease than most other common forms of viral encephalitis. CSF glucose was higher because the blood glucose levels were higher.

Conclusions
===========

In our patient the OMS appeared associated with West Nile encephalitis and had an unfavorable evolution despite treatment with corticosteroids. It is essential to combine available treatments but the evolution is less satisfactory.
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